Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Osteoarthritis
•
General Rheumatology
Do you consider metformin as a disease-modifying adjunct in the management of patients with OA, particularly in those with comorbid metabolic syndrome or type 2 diabetes?
Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity A Randomized Clinical Trial
Related Questions
What is the role of the rheumatologist in recommending and providing GLP-1 medications to their patients given the benefits across many disease domains including osteoarthritis?
Are there any successful disease modifying therapy for diffuse idiopathic skeletal hyperostosis (DISH)?
Would you add immunosuppression for recurrent calcium kidney stones in a patient with sarcoidosis?
How do you evaluate and manage patients with lupus who are having issues with decreased libido?
Do you have any experience with compounded iguratimod either as adjunctive therapy or monotherapy for rheumatoid arthritis, Sjogrens, or axial spondyloarthropathy?
How do you treat idiopathic acute anterior uveitis that recurs immediately after a course of topical corticosteroids?
Is it better to give dose 2 of the mRNA 2024-2025 Covid-19 vaccine at month 2 or month 6 after dose 1 in moderately immunocompromised patients?
What are your recommendations for perioperative management of DMARDs and biologics in patients undergoing bariatric surgery?
How do you approach a patient with Paget’s disease of bone with elevated alkaline phosphatase and history of chronic kidney disease?
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
